Navigating the Nonrefundable Constraint of the Indiana Research Expense Tax Credit

A nonrefundable tax credit serves to reduce a taxpayer’s liability dollar-for-dollar, but it cannot generate a cash refund if the credit amount exceeds the total tax owed. This means the benefit is capped by the current year’s tax liability, requiring strategic management of any unused excess credit.

The nonrefundable classification is a critical, yet often complex, feature of many state tax incentives, including the Indiana Research Expense Tax Credit (the “Credit”), established under Indiana Code (IC) 6-3.1-4. While the Credit offers substantial relief against the Indiana Adjusted Gross Income Tax (AGIT) liability based on qualified research expenses (QREs), its nonrefundable status means that any calculated credit exceeding the current year’s liability must be carried forward to subsequent years to be realized. Maximizing the economic value of this incentive demands sophisticated tax modeling, rigorous tracking of credit expiration dates, and strict adherence to the Indiana Department of Revenue (DOR) compliance mandates.

Understanding Nonrefundable Credits: Mechanics and Limitations

The concept of a nonrefundable credit is a key mechanism used by tax jurisdictions to incentivize specific, desired economic activities, such as research and development (R&D), without incurring direct negative cash flow impacts through immediate tax refunds.

The Operational Difference: Nonrefundable vs. Refundable Credits

The core difference between tax credit types lies in their ability to generate cash flow when the credit surpasses the tax due.

• Nonrefundable Credits (The Indiana Model): These credits function purely as offsets against tax liability. They reduce the amount of tax owed down to zero but cannot result in a tax refund or increase a tax refund that the taxpayer might otherwise receive.1 Stated simply, the financial savings cannot exceed the final tax liability.2 For example, if a company owes $50,000 in AGIT liability and earns a $75,000 nonrefundable R&D credit, only $50,000 of the credit may be utilized in that period. The remaining $25,000 is considered nonrefundable excess; if the statute permits carryover, this excess amount becomes an asset to be applied in future tax years.2
• Refundable Credits: These credits are treated like tax payments already made. If the sum of refundable credits exceeds the tax due, the Internal Revenue Service (IRS) or the state sends the taxpayer a refund for the difference. The Earned Income Credit is a common federal example of a refundable credit.2
• Partially Refundable Credits: This hybrid structure allows a specific portion of the credit to be refundable (treated as payment) while the remainder is nonrefundable, thereby offsetting tax liability only.2

Strategic Implications: Utilization and Deferral Risk

The nonrefundable status means the Indiana R&D credit functions as a future tax shield rather than an immediate cash injection. This distinction has profound implications for corporate financial planning. Companies engaged in R&D, particularly high-growth, early-stage firms, often operate with significant initial losses or may have large Net Operating Loss (NOL) carryovers that eliminate current tax liability. When tax liability is zero, generating a nonrefundable credit offers no immediate financial benefit; the entire amount must be deferred. The true value of the credit is therefore realized only when the company achieves sufficient profitability to incur an AGIT liability within the statutory expiration window.

Indiana Credit Application Priority (IC 6-3.1-1-2)

The order in which various credits are applied is crucial, as it determines which credits are utilized first. Indiana Code establishes a priority sequence for applying state tax liability credits 3:

1. First, credits that are nonrefundable but cannot be carried over.
2. Second, the credits that are nonrefundable but that may be carried over and applied against a subsequent year’s liability. The Indiana Research Expense Credit falls into this category.4
3. Third, the credits that are refundable.

This hierarchy ensures that the R&D credit, which has a carryover provision, is applied before any refundable credits (which generate cash) but after any nonrefundable credits that might expire if not used immediately.

Statutory Framework of the Indiana Research Expense Credit (IC 6-3.1-4)

The Indiana Research Expense Credit provides a specific incentive for increasing qualified research activities conducted within the state.5 The foundational legal text for the credit is found in IC 6-3.1-4.5

Legal Authority and Definitions

The administration of the Indiana credit is highly dependent upon federal standards while requiring explicit localization.

• Qualified Research Expense (QRE): Indiana generally defines QREs by referencing Section 41(b) of the Internal Revenue Code (IRC).5 This linkage was formalized by HEA 1472-2015, effective January 1, 2016, which amended the state’s definitions to align with the federal statute.7
• Localization Requirement: While the definition of what constitutes qualified research is federal, the expense must qualify as “Indiana qualified research expense” and must be incurred for research conducted in Indiana.8 This localization is a key area of compliance, requiring robust documentation that ties expenses to specific in-state activities.

Eligibility and Pass-Through Mechanics

The Indiana Research Expense Credit is broadly available to various entity structures that incur Indiana research expenses and possess AGIT liability imposed under Indiana Code (IC) 6-3.8

• Eligible Entities: This includes individuals, corporations, limited liability companies (LLCs), limited liability partnerships (LLPs), trusts, and partnerships.8 Trusts and estates can claim the credit against their own liabilities, though generally, beneficiaries of these entities are not eligible, with the exception of Grantor Trusts.9
• Pass-Through Entities (PTEs): S corporations, partnerships, LLCs, and LLPs, which typically do not pay entity-level income tax, calculate the credit at the entity level and then allocate it to their shareholders, partners, or members. The PTE must issue a Schedule IN K-1 to support the claim made by the owners.8

The distribution of the credit to owners means that the nonrefundable constraint is applied at the individual taxpayer level, tied to each owner’s personal AGIT liability. This dispersal of the utilization challenge requires meticulous record-keeping and coordination between the PTE and its owners to ensure the earned credit is fully utilized before the statutory 10-year period expires.

Calculation Methodologies and Statutory Rates

Indiana provides taxpayers with a choice between two calculation methods: the standard incremental method and an alternative incremental credit (AIC) method, both designed to reward investment growth in R&D activities.7

Standard Calculation (IC 6-3.1-4-2)

The standard methodology calculates the credit based on the excess of current year QREs over a determined base period amount, applying a tiered percentage structure:

• Tier 1: The potential value of the credit is 15% of the increase in Indiana QREs over the base period amount, up to the first $1 million of that excess.5
• Tier 2: A credit percentage of up to 10% is applied to any excess of the Indiana QREs over the base period amount that is greater than $1 million.7

Base Amount Determination: The Localization Modification

The base amount calculation in Indiana critically modifies the federal methodology to account solely for in-state activity. The base amount is generally defined by IRC Section 41(c).8 However, the Indiana statute requires that the taxpayer’s fixed base percentage and average annual gross receipts used in the calculation must be modified to consider only Indiana qualified research expenses and gross receipts attributable to Indiana.8 Furthermore, the annual minimum base amount may not be less than 50% of the current year’s Indiana QRE.8

This localization requirement introduces a layer of complexity and audit focus. Taxpayers must rigorously demonstrate the methodology used to attribute historical QREs and gross receipts accurately to the state. This localization determines the size of the incremental credit generated. If a company has expanded R&D in Indiana, the localized base amount may be lower, resulting in a larger credit. Conversely, a high localized base could restrict the current credit, underscoring the necessity of detailed historical data.

Alternative Incremental Credit (AIC) (IC 6-3.1-4-2.5)

Taxpayers may elect to calculate the credit using the AIC method.7

• Standard AIC: The amount of the credit is 10% of the current year’s Indiana QRE that exceeds 50% of the taxpayer’s average Indiana QRE for the three taxable years preceding the current year.7
• Start-up Rule: If the taxpayer did not have Indiana QREs in any one of the three preceding years, the calculation simplifies: the credit amount is equal to 5% of the taxpayer’s current year Indiana QRE.7

The Nonrefundable Constraint: Unused Credits and Carryforward Mandate

The defining financial constraint of the Indiana Research Expense Credit is its nonrefundable status, which makes the statutory carryforward provision the sole mechanism for recovering excess value.10

The Nonrefundable Mandate and Carryforward Period

The Indiana statute explicitly mandates that a taxpayer is not entitled to any carryback or refund of any unused credit.10 This nonrefundable excess, the amount of the calculated credit that exceeds the current AGIT liability, must be carried forward.

Applicable to taxable years beginning after December 31, 2005, credits may be carried forward for a period of 10 taxable years.7 This 10-year limit establishes the finite life of the credit asset.

Compliance Requirement: Credit Vintage Tracking

Because the carryforward period is limited to 10 years, accurate tracking of the credit’s vintage (the year the credit was originally generated) is essential for compliance and asset preservation. A First-In, First-Out (FIFO) methodology must be employed for applying carryforward credits. This ensures that older credits are utilized before they expire, thereby preventing the permanent forfeiture of the nonrefundable excess.

Companies must integrate R&D credit utilization into their long-term financial projections. Analysis of utilization patterns indicates that the R&D incentives—which combine to provide more than $100 million in annual tax relief—are frequently utilized by a small number of large businesses.11 These entities must rigorously track and manage substantial carryforward balances to fully capture the incentive’s economic value over the 10-year period.

DOR Compliance and Documentation

To claim the Indiana Research Expense Credit, taxpayers must submit specific forms to the DOR and adhere to requirements designed to validate the localized nature of the expense and ensure consistency with federal filing positions.

Required Filing Documents

Taxpayers claiming the credit must complete and enclose specific documentation with their annual state income tax return (such as Form IT-20 for corporations):

• Schedule IT-20REC: This Indiana Research Expense Credit schedule is the primary form used to calculate the credit based on Indiana-specific QREs and the modified base amount.8
• Federal Form 6765: A copy of the federal Form 6765 (Credit for Increasing Research Activities) or federal Form 8820 must be attached to the IT-20REC.8

Substantiating Indiana Qualified Research Expenses (QREs)

Since the state adopts the complex federal definition of QREs, the DOR’s audit focus shifts predominantly to verifying the localization of those expenses. Documentation must confirm that the expenses were incurred for research activities physically conducted within Indiana. This requires substantiating the following factors 12:

• The place(s) in Indiana where services are performed.
• The Indiana location of the person(s) performing the services.
• The Indiana location where qualified research supplies are consumed.
• Any other factors relevant to activities in Indiana.

These localization requirements often necessitate detailed time-tracking, organizational charts, and financial records that bridge the gap between accounting systems (which measure expenditures) and the statutory requirements of IRC $\S41$.5

Federal Consistency and Disclosure Mandate

Indiana imposes a unique disclosure requirement under IC 6-3.1-4-8 regarding the consistency between state and federal claims. If a taxpayer claims the Indiana credit under IC 6-3.1-4 but has not claimed the corresponding federal credit for those same qualified research expenses, the taxpayer must formally disclose the reasons for the disparity to the DOR.9

This mandate serves as a critical audit checkpoint. The DOR uses the attached federal Form 6765 as a baseline reference. The requirement to explain divergence suggests that the DOR is keenly interested in any claimed QREs that qualify at the state level but not federally. Such discrepancies usually center on the localization methodology (i.e., the expense did not qualify federally because it occurred outside the US, but it qualifies for Indiana because it occurred within the state) or specific differences in base amount calculations. This directly links federal R&D compliance standards to Indiana audit exposure.

Practical Application Example: Navigating Nonrefundability and Carryforward

The following scenario illustrates how the nonrefundable limitation restricts current utilization and triggers the necessary 10-year carryforward mechanism.

Scenario: Innovate Dynamics LLC (IDL), a pass-through entity, generates a significant Indiana R&D credit in Year 1 but has limited tax capacity.

Analysis:

1. Year 1 Constraint: IDL calculates a $60,000 credit, which is allocated to Partner A. Partner A’s AGIT liability is only $20,000. Due to the credit’s nonrefundable nature, utilization is capped at $20,000, reducing the liability to zero. The nonrefundable excess of $40,000 is preserved as a carryforward asset, tagged with the Year 1 vintage, which must be utilized within 10 years.7
2. Year 2 Recovery: In Year 2, Partner A’s liability increases to $55,000. The available credit is $60,000 (the $20,000 generated in Year 2 plus the $40,000 Year 1 carryforward). Partner A utilizes $55,000 of the total available credit to eliminate the liability. The $40,000 Year 1 vintage is fully consumed, and $15,000 of the Year 2 vintage is consumed.
3. Result: A small remaining nonrefundable excess of $5,000 (Year 2 vintage) is carried forward to Year 3. This successful multi-year utilization demonstrates effective management of the nonrefundable credit, ensuring that the full economic incentive is eventually captured within the statutory period.

Contextualizing the Incentive: R&D Policy and Complementary Benefits

The Research Expense Credit is one of several tax incentives Indiana uses to support innovation, based on the economic theory that technological progress is a fundamental driver of productivity and long-term economic output.11

Economic Impact and Utilization Trends

The provision of R&D tax relief helps to reduce the financial risk of research projects by basing incentives on the amount of research input (expense) rather than unproven output metrics (like patents).11 Combined, Indiana’s R&D incentives—the income tax credit and the sales tax exemption—provide more than $100 million in annual tax relief.11

While this relief is significant, state-level R&D incentives are typically smaller than national incentives, and their primary impact may be realized in the long term, potentially resulting in the relocation of R&D activity to Indiana from competing states.11 Utilization analysis shows that the research expense credit is disproportionately used by a small number of large businesses that possess the current or forecasted tax capacity necessary to effectively utilize the nonrefundable credit.11

The Complementary Incentive: Sales and Use Tax Exemption (IC 6-2.5-5-40)

Indiana offers a separate, significant incentive that complements the income tax credit: a 100% sales tax exemption for qualified R&D equipment and property purchased for use in Indiana.5

This exemption is structurally distinct from the income tax credit. While the R&D income tax credit is limited by the AGIT liability and therefore deferred for many companies, the sales tax exemption provides an immediate, dollar-for-dollar reduction in the cost of assets at the point of transaction.5 For cash-constrained firms or those currently operating at a loss, the sales tax exemption offers a more immediate and reliable source of savings.

To claim this exemption, the purchaser must complete and provide Form ST-105, Indiana Sales and Use Tax Exemption Certificate, to the seller at the time of purchase. Businesses must maintain detailed records to substantiate the purchase price of the equipment used in qualified research.5

Conclusion: Maximizing the Value of the Nonrefundable R&D Credit

The Indiana Research Expense Tax Credit under IC 6-3.1-4 represents a valuable, nonrefundable tax asset designed to drive innovation investment. Because the credit cannot generate a cash refund, its full economic potential is unlocked only when the taxpayer successfully forecasts and manages its utilization against future state income tax liability.

Effective utilization of this nonrefundable asset requires precision in three core compliance and planning areas:

1. Rigorous Documentation of Localization: Taxpayers must go beyond simply calculating QREs based on federal guidelines. They must maintain clear, auditable documentation that proves the research activities, personnel services, and consumption of supplies occurred specifically within Indiana, satisfying the statutory localization requirement.12
2. Integrated Federal and State Compliance: The required submission of federal Form 6765 alongside the state’s IT-20REC, coupled with the disclosure mandate for any significant discrepancies, necessitates a fully integrated and justifiable methodology for calculating both credits.9 This practice minimizes audit risk by proactively addressing potential inquiries regarding localization differences.
3. Proactive Carryforward Asset Management: Due to the nonrefundable nature and the mandatory 10-year expiration window 7, businesses must treat carryforward credits as a depleting asset. Implementation of robust tracking systems that identify the vintage of each carryforward dollar, alongside long-term income projections, is essential to ensure older credits are utilized before they are permanently forfeited.

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/